Videos

Aaron Steffenhagen, PharmD, BCPS, clinical pharmacy manager at University of Wisconsin Hospital and Clinics, discusses the typical medications found in a crash cart.

Aaron Steffenhagen, PharmD, BCPS, clinical pharmacy manager at University of Wisconsin Hospital and Clinics, discusses how pharmacists can get more involved before, during, and after codes.

Aaron Steffenhagen, PharmD, BCPS, clinical pharmacy manager at University of Wisconsin Hospital and Clinics, discusses some ways pharmacists have helped in cardiopulmonary resuscitation efforts.

Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses the benefits and risks of off-label use of new oral anticoagulants.

Teresa Rubio, PharmD, of the FDA Office on Health and Constituent Affairs, describes the process by which pharmacists can file reports with MedWatch.

This weekly video program highlights the latest in pharmacy news, product news, and more.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the trend of larger entities absorbing independent specialty pharmacies.

Teresa Rubio, PharmD of the FDA Office on Health and Constituents Affairs describes the types of adverse drug events that pharmacists should report to MedWatch.

Natasha Nicol, PharmD, FASHP, director of Global Patient Safety Affairs at Cardinal Health, talks about how a pharmacist can be proactive in reducing the chance of errors.

Natasha Nicol, PharmD, FASHP, director of Global Patient Safety Affairs at Cardinal Health, provides prevention strategies to reduce medication errors.

Matthew C. Grissinger, RPh, FISMP, FASCP, director, of error reporting programs at the Institute for Safe Medication Practices, discusses medication use risk outside the pharmacy.

James Hoffman, PharmD, MS, FASHP, describes negative trends affecting the pharmacy workforce.

Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses how a patient's renal function affects appropriate dosing of new oral anticoagulants.

James Hoffman, PharmD, MS, FASHP, explains how pharmacy practice settings may change going forward.

Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group, discusses developing trends in specialty drug cost management.

Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses how NOAC dosing for obese patients differs from NOAC dosing for non-obese patients.

Joel Marrs, PharmD, BCPS-AQ Cardiology, FASHP, discusses the role of the pharmacist in optimizing care for heart failure with reduced ejection fracture patients.

James Hoffman, PharmD, MS, FASHP of St. Jude Children's Research Hospital, outlines how pharmacists can use their knowledge of key trends to patient care improvement efforts.

Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic gives examples of certain off-label uses for NOACs that seem promising.

Joel Marrs, PharmD, BCPS-AQ Cardiology, FASHP, discusses how the approval of Entresto changed the heart failure care landscape.

Teresa Rubio, PharmD, of the FDA Office on Health and Constituents outlines why it is important for pharmacists to report to MedWatch.

James Hoffman, PharmD, MS, FASHP of St. Jude Children's Research Hospital, discusses some of the major trends in pharmacy. This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.

Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses the role of platelet aggregation inhibitors in ACS management.

James Hoffman, PharmD, MS, FASHP of St. Jude Children's Research Hospital, describes how the growing trend of patient empowerment will affect the practice of pharmacy going forward.

Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses the different nuances pharmacists have to consider when using platelet aggregation inhibitors in different patient populations.

David Lassen, chief clinical officer at Prime Therapeutics, discusses implications for specialty pharmacy from health care reform.

Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses the role of the pharmacist in ACS management with platelet aggregation inhibitors.

Liz Tiefenthaler, president of Pharm Fresh Media, talks about some ways a pharmacy can differentiate itself from its competition.

Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, talks about what his experience has been like as an adviser for the South Carolina College of Pharmacy student business plan team.

Carlos Aquino, founder and president of PharmaDiversion LLC, talks about what happens to a pharmacy if it is found to be out of compliance with DEA regulations or federal statutes.